-transparent.png){kind=logo}
Seventeen patients with advanced and recurrent squamous cell cervical cancer were treated with a combination of cisplatin and bleomycin. One complete and nine partial responses were observed (53%). The median duration of response was 8 months and the median survival was 12.7 months (5 months for nonresponders). Response was documented, particularly in patients with nodal disease and lung metastases. No life-threatening toxic effects were reported. This combination appears to be as effective as other combinations, has low toxicity, is well-tolerated, and merits further study.
Related Publications
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
March 1989,
Journal of the National Cancer Institute,
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
January 2004,
Gynecologic and obstetric investigation,
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
August 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
August 1984,
Hinyokika kiyo. Acta urologica Japonica,
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
January 1981,
Cancer clinical trials,
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
February 1984,
Obstetrics and gynecology,
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
March 1983,
Cancer,
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
September 1999,
British journal of cancer,
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
June 1996,
American journal of clinical oncology,
B Bloch, and
C P Nel, and
A Kriel, and
J Atad, and
G Goldberg
July 1986,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
